Loading clinical trials...
Loading clinical trials...
Evaluation of Safety and Efficacy of Raltegravir/Darunavir Combination in Antiretroviral-Naive Patients
Conditions
Interventions
Raltegravir
Darunavir
+2 more
Locations
2
United States
Dallas VA Medical Center
Dallas, Texas, United States
Parkland Health & Hospital System
Dallas, Texas, United States
Start Date
January 1, 2009
Primary Completion Date
October 1, 2012
Completion Date
December 1, 2012
Last Updated
September 8, 2014
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Dallas VA Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions